In France, the new embolization endoprosthesis named Silk (Balt) will be reimbursed €8,944.08 from June 10, 2020 #BALT #Embolization #Endoprosthesis #Stent #Stroke #interventional #percutaneous #Silk #LPPR #Reimbursement #Marketaccess #Listing #Listeensus #Tariff #Addonpayment #France #Remboursement #Accesaumarché #Tarif #Inscription #embolisation #endoprothese #interventionnel #Santé

In France, the new Patent Foramen Ovale (PFO) occluder named Amplatzer (Abbott) will be reimbursed €3,735 from June 03, 2020 #Abbott, #Exovascular #Heart #Stroke #Amplatzer #Occluder #interventional #percutaneous #PFO #LPPR #Reimbursement #Marketaccess #Listing #Listeensus #Tariff #Addonpayment #France #Remboursement #Accesaumarché #Tarif #Inscription #exovasculaire #AVC #Santé

In 2017, there were only 2 dominent Companies : Medtronic as the leader and Stryker as the challenger. In February 2019, Johnson & Johnson comes to the market with its Embotrap product. Shares change move soon. #Medtronic #Stryker #Neuravi #Johnson_Johnson #Solitaire #Trevo #Embotrap #Thrombectomy #Ischemic #Stroke #Share #Hospital #Market_research #Market_data #Market_Intellligence #Analytics #Thrombectomie #AVC #Hôpital #Analyse #Données #Santé #Neurovasculaire Follow us on